Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Can Stem Cell Transplantation Improve Survival Rates in Patients with Systemic Sclerosis?

  |  

Low eGFR prior to transplant was identified as a risk factor for adverse outcomes after AHSCT.

For complete details, including source material, refer to the full study.   

ADVERTISEMENT
SCROLL TO CONTINUE

Excerpted and adapted from:

Georges GE, Khanna D, Wener MH, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation for diffuse cutaneous systemic sclerosis: Identifying disease risk factors for toxicity and long-term outcomes in a prospective, single-arm trial. Arthritis Rheumatol. 2025 May;77(5):571–581.

Related Articles
    HSCT for Severe Autoimmune Diseases

    HSCT for Severe Autoimmune Diseases

    Despite the innovations of new biologics and disease-modifying anti-rheumatic drugs, a large unmet need remains for patients with rheumatic autoimmune disease. Treatment remains limited for many conditions, including for conditions with a dim prognosis, such as systemic sclerosis.1 One promising treatment avenue is hematopoietic stem-cell transplantation (HSCT). Here, we provide background on HSCT for severe…